%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2020-07-10T13:18:54+05:30Arbortext Advanced Print Publisher2020-07-12T07:02:12-07:002020-07-12T07:02:12-07:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalLeukemia & Lymphoma© 2020 Informa UK Limited, trading as Taylor & Francis Group001-61610.1080/10428194.2020.1789627https://doi.org/10.1080/10428194.2020.1789627application/pdf10.1080/10428194.2020.1789627en-USC reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosisTaylor & FrancisLeukemia & Lymphoma, 2020. doi: 10.1080/10428194.2020.1789627Lucijanic MarkoGalusic DavorKrecak IvanSedinic MartinaSoric EnaHolik HrvojePerisa VlatkaMoric Peric MartinaZekanovic IvanStoos-Veic TajanaKusec RajkoMyeloproliferative neoplasmmyelofibrosisC reactive proteinalbuminsurvivalVoR2020-07-12truewww.tandfonline.com10.1080/10428194.2020.1789627www.tandfonline.comtrue2020-07-1210.1080/10428194.2020.1789627
endstream
endobj
4 0 obj
<>stream
xYKo7(xw@ANm$EJ'M1I"NVo{mAC҉&<^bTU=X]5އZ)Qw6u.alS*{YYHuM|qwwa:Bxo02wkޤ,!hM:,&2xeunrݩ`TV*d?_zTLc+3#š[Hw5#حM,Huׇͤ IxF6TNYo9z$W~5U觡?ϧ?OF"|\ .b).;y|~UNs2L_N\qa2V%m
̒PiY)믯?$+&_.qFu. SRBm\9ߗC@e:G&U9]FO,Y 8 AFS`ԫܹed^u]8$eR>ij[%)9^HzBɎZDrJp
㻽ںDIT